These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34915086)

  • 21. Detection of SARS-CoV-2 and the L452R spike mutation using reverse transcription loop-mediated isothermal amplification plus bioluminescent assay in real-time (RT-LAMP-BART).
    Iijima T; Ando S; Kanamori D; Kuroda K; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Seki M; Hoshino T
    PLoS One; 2022; 17(3):e0265748. PubMed ID: 35312732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing.
    Nasereddin A; Golan Berman H; Wolf DG; Oiknine-Djian E; Adar S
    Microbiol Spectr; 2022 Aug; 10(4):e0073622. PubMed ID: 35758686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
    Zahradník J; Marciano S; Shemesh M; Zoler E; Harari D; Chiaravalli J; Meyer B; Rudich Y; Li C; Marton I; Dym O; Elad N; Lewis MG; Andersen H; Gagne M; Seder RA; Douek DC; Schreiber G
    Nat Microbiol; 2021 Sep; 6(9):1188-1198. PubMed ID: 34400835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
    Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G
    Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revealing patterns of SARS-CoV-2 variant emergence and evolution using RBD amplicon sequencing of wastewater.
    Chen X; Balliew J; Bauer CX; Deegan J; Gitter A; Hanson BM; Maresso AW; Tisza MJ; Troisi CL; Rios J; Mena KD; Boerwinkle E; Wu F
    J Infect; 2024 Nov; 89(5):106284. PubMed ID: 39341403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
    Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
    Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida.
    Carattini YL; Griswold A; Williams S; Valiathan R; Zhou Y; Shukla B; Abbo LM; Parra K; Jorda M; Nimer SD; Sologon C; Gallegos HR; Weiss RE; Ferreira T; Memon A; Paige PG; Thomas E; Andrews DM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic surveillance of SARS-CoV-2 Spike gene by sanger sequencing.
    Salles TS; Cavalcanti AC; da Costa FB; Dias VZ; de Souza LM; de Meneses MDF; da Silva JAS; Amaral CD; Felix JR; Pereira DA; Boatto S; Guimarães MAAM; Ferreira DF; Azevedo RC
    PLoS One; 2022; 17(1):e0262170. PubMed ID: 35051202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes.
    Chatterjee D; Tauzin A; Laumaea A; Gong SY; Bo Y; Guilbault A; Goyette G; Bourassa C; Gendron-Lepage G; Medjahed H; Richard J; Moreira S; Côté M; Finzi A
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Analysis of Spike from SARS-CoV-2 Variants Reveals the Role of Distinct Mutations in Neutralization Potential and Viral Infectivity.
    Kuzmina A; Wattad S; Engel S; Rosenberg E; Taube R
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant.
    Ma W; Yang J; Fu H; Su C; Yu C; Wang Q; de Vasconcelos ATR; Bazykin GA; Bao Y; Li M
    Genomics Proteomics Bioinformatics; 2022 Feb; 20(1):60-69. PubMed ID: 35033679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination.
    Hernández-Luis P; Aguilar R; Pelegrin-Pérez J; Ruiz-Olalla G; García-Basteiro AL; Tortajada M; Moncunill G; Dobaño C; Angulo A; Engel P
    Front Immunol; 2022; 13():816389. PubMed ID: 35464418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of SARS-CoV-2 variants from patient specimens in Nevada from October 2020 to August 2021.
    Payen SH; Gorzalski A; Siao DD; Pandori M; Verma SC; Rossetto CC
    Infect Genet Evol; 2023 Jul; 111():105434. PubMed ID: 37059256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
    Li X; Zhang L; Chen S; Ji W; Li C; Ren L
    Infect Genet Evol; 2021 Sep; 93():104971. PubMed ID: 34146731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.